{"id":8508,"date":"2025-09-05T19:33:09","date_gmt":"2025-09-05T16:33:09","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8508"},"modified":"2025-09-05T19:33:09","modified_gmt":"2025-09-05T16:33:09","slug":"advanced-risk-score-predicts-long-term-survival-after-mitral-valve-surgery","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/advanced-risk-score-predicts-long-term-survival-after-mitral-valve-surgery\/","title":{"rendered":"Advanced Risk Score Predicts Long-Term Survival After Mitral Valve Surgery"},"content":{"rendered":"<div>Advanced Risk Score Predicts Long-Term Survival After Mitral Valve Surgery<\/div>\n<div><\/div>\n<div>Source: 2025<\/div>\n<div>Original research: The Annals of Thoracic Surgery<\/div>\n<div><span> 1. Background<\/span><\/div>\n<div><span> \u2022 Mitral valve replacement (MVR) is recognized for its significant operative risks, leading many high-risk patients to be excluded from surgical management<\/span><\/div>\n<div><span> \u2022 The STS Risk Calculator is widely used for short-term mortality prediction.<\/span><\/div>\n<div><span> \u2022 This study assessed its value for long-term (5-year) survival prediction.<\/span><\/div>\n<div><span> 2. Study Design<\/span><\/div>\n<div><span> \u2022 Single-center, high-volume institution (2010\u20132023).<\/span><\/div>\n<div><span> \u2022 Nearly 1,500 patients screened; final cohort 855 patients.<\/span><\/div>\n<div><span> \u2022 Median age: 64 years; 63% women; 82% white.<\/span><\/div>\n<div><span> \u2022 Case urgency: 75.5% elective, 23% urgent, 1.4% emergent, 0.1% salvage.<\/span><\/div>\n<div><span> \u2022 Excluded patients with concomitant AVR or CABG.<\/span><\/div>\n<div><span> 3. Risk Categories (STS PROM)<\/span><\/div>\n<div><span> \u2022 Low-risk: &lt;3%<\/span><\/div>\n<div><span> \u2022 Intermediate-risk: 3\u20136%<\/span><\/div>\n<div><span> \u2022 High-risk: &gt;6%<\/span><\/div>\n<div><span> \u2022 Mean PROM for cohort: 5.9%.<\/span><\/div>\n<div><span> 4. Key Findings<\/span><\/div>\n<div><span> \u2022 5-year survival rates:<\/span><\/div>\n<div><span> \u2022 Low-risk: 90.8%<\/span><\/div>\n<div><span> \u2022 Intermediate-risk: 75.5%<\/span><\/div>\n<div><span> \u2022 High-risk: 56.4%<\/span><\/div>\n<div><span> \u2022 High-risk patients had more comorbidities (HTN, diabetes, MI, HF).<\/span><\/div>\n<div><span> \u2022 Independent predictors of worse long-term survival:<\/span><\/div>\n<div><span> \u2022 Preoperative dialysis<\/span><\/div>\n<div><span> \u2022 Hypertension<\/span><\/div>\n<div><span> \u2022 Urgent\/emergent status<\/span><\/div>\n<div><span> 5. Conclusions<\/span><\/div>\n<div><span> \u2022 STS PROM is effective for long-term risk stratification in MVR patients.<\/span><\/div>\n<div><span> \u2022 Provides refined criteria to identify candidates for surgery vs. alternative therapies (e.g., transcatheter approaches).<\/span><\/div>\n<div><span> \u2022 Enhances patient selection and may guide shared decision-making.<\/span><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/www.annalsthoracicsurgery.org\/article\/S0003-4975(25)00752-0\/fulltext\">https:\/\/www.annalsthoracicsurgery.org\/article\/S0003-4975(25)00752-0\/fulltext<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Advanced Risk Score Predicts Long-Term Survival After Mitral Valve Surgery Source: 2025 Original research: The Annals of Thoracic Surgery 1. Background \u2022 Mitral valve replacement (MVR) is recognized for its significant operative risks, leading many high-risk patients to be excluded from surgical management \u2022 The STS Risk Calculator is widely used for short-term mortality prediction. [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8508","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8508"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8508\/revisions"}],"predecessor-version":[{"id":8509,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8508\/revisions\/8509"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}